ES2098030T3 - Nuevos agentes cardioprotectores. - Google Patents

Nuevos agentes cardioprotectores.

Info

Publication number
ES2098030T3
ES2098030T3 ES93907332T ES93907332T ES2098030T3 ES 2098030 T3 ES2098030 T3 ES 2098030T3 ES 93907332 T ES93907332 T ES 93907332T ES 93907332 T ES93907332 T ES 93907332T ES 2098030 T3 ES2098030 T3 ES 2098030T3
Authority
ES
Spain
Prior art keywords
cardioprotectors
agents
new
useful
tetraalkyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES93907332T
Other languages
English (en)
Inventor
J Martin Grisar
Margaret A Petty
Frank Bolkenius
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Aventis Pharmaceuticals Inc
Original Assignee
Merrell Dow Pharmaceuticals Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Merrell Dow Pharmaceuticals Inc filed Critical Merrell Dow Pharmaceuticals Inc
Application granted granted Critical
Publication of ES2098030T3 publication Critical patent/ES2098030T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D493/00—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system
    • C07D493/02—Heterocyclic compounds containing oxygen atoms as the only ring hetero atoms in the condensed system in which the condensed system contains two hetero rings
    • C07D493/08—Bridged systems
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A61K31/35—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin having six-membered rings with one oxygen as the only ring hetero atom
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
    • A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P39/00—General protective or antinoxious agents
    • A61P39/06—Free radical scavengers or antioxidants
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D311/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings
    • C07D311/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only hetero atom, condensed with other rings ortho- or peri-condensed with carbocyclic rings or ring systems
    • C07D311/04—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring
    • C07D311/22—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4
    • C07D311/24—Benzo[b]pyrans, not hydrogenated in the carbocyclic ring with oxygen or sulfur atoms directly attached in position 4 with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached in position 2

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Engineering & Computer Science (AREA)
  • Epidemiology (AREA)
  • Vascular Medicine (AREA)
  • Cardiology (AREA)
  • Biochemistry (AREA)
  • Toxicology (AREA)
  • Pain & Pain Management (AREA)
  • Rheumatology (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Urology & Nephrology (AREA)
  • Polyesters Or Polycarbonates (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
  • Polymers With Sulfur, Phosphorus Or Metals In The Main Chain (AREA)
  • Heterocyclic Carbon Compounds Containing A Hetero Ring Having Oxygen Or Sulfur (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Paints Or Removers (AREA)
  • Macromolecular Compounds Obtained By Forming Nitrogen-Containing Linkages In General (AREA)
  • Pyrane Compounds (AREA)
  • Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
  • Measurement Of The Respiration, Hearing Ability, Form, And Blood Characteristics Of Living Organisms (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
  • Investigating Or Analysing Biological Materials (AREA)
  • Low-Molecular Organic Synthesis Reactions Using Catalysts (AREA)

Abstract

ESTA INVENCION ES RELATIVA A CIERTOS DERIVADOS DE ACIDOS HIDROXI DE 3,4 NZOPIRANO CESOS Y USOS INTERMEDIOS PARA SU PREPARACION Y A SU USO COMO CAPTORES DE RADICALES LIBRES USADOS EN EL TRATAMIENTO DE DAÑOS DE TEJIDOS IMPLICADOS CON RADICALES LIBRES DE OXIGENO.
ES93907332T 1992-04-06 1993-03-08 Nuevos agentes cardioprotectores. Expired - Lifetime ES2098030T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
EP92400957 1992-04-06

Publications (1)

Publication Number Publication Date
ES2098030T3 true ES2098030T3 (es) 1997-04-16

Family

ID=8211647

Family Applications (1)

Application Number Title Priority Date Filing Date
ES93907332T Expired - Lifetime ES2098030T3 (es) 1992-04-06 1993-03-08 Nuevos agentes cardioprotectores.

Country Status (18)

Country Link
EP (1) EP0635010B1 (es)
JP (1) JP3248183B2 (es)
KR (1) KR100243820B1 (es)
AT (1) ATE146175T1 (es)
AU (1) AU667889B2 (es)
CA (1) CA2132745C (es)
DE (1) DE69306559T2 (es)
DK (1) DK0635010T3 (es)
ES (1) ES2098030T3 (es)
FI (1) FI112658B (es)
GR (1) GR3022471T3 (es)
HU (1) HU217426B (es)
IL (1) IL105320A (es)
NO (1) NO307088B1 (es)
NZ (1) NZ251131A (es)
TW (1) TW232014B (es)
WO (1) WO1993020058A1 (es)
ZA (1) ZA932326B (es)

Families Citing this family (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5721233A (en) * 1992-04-06 1998-02-24 Merrell Pharmaceuticals Inc. Derivatives of 2,3-dihydro benzofuranols
US5545660A (en) * 1992-04-07 1996-08-13 Merrell Pharmaceuticals Inc. Hydrazide derivatives of 3,4-dihydro-2H-1-benzopyrans
US5451603A (en) * 1993-03-11 1995-09-19 Zymogenetics, Inc. 3,4-diarylchromans for treatment of dermatitis
US5416098A (en) * 1993-12-30 1995-05-16 Zymogenetics, Inc. Method for treating dermatitis and related conditions
CN115073413B (zh) * 2022-05-17 2023-06-02 中山大学 一种苯并环醚类倍半萜类化合物及其制备方法与应用

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3947473A (en) * 1972-12-22 1976-03-30 Hoffman-La Roche Inc. Antioxidant chroman compounds
CA2002649C (en) * 1988-11-14 2000-06-06 Margaret Petty Cardioprotective tocopherol analogs

Also Published As

Publication number Publication date
CA2132745A1 (en) 1993-10-14
AU3797293A (en) 1993-11-08
FI944656A (fi) 1994-10-05
GR3022471T3 (en) 1997-05-31
NZ251131A (en) 1996-01-26
EP0635010B1 (en) 1996-12-11
FI944656A0 (fi) 1994-10-05
ZA932326B (en) 1993-10-18
FI112658B (fi) 2003-12-31
DK0635010T3 (da) 1996-12-30
HU217426B (hu) 2000-01-28
IL105320A0 (en) 1993-08-18
JP3248183B2 (ja) 2002-01-21
KR100243820B1 (ko) 2000-03-02
EP0635010A1 (en) 1995-01-25
KR950700896A (ko) 1995-02-20
ATE146175T1 (de) 1996-12-15
WO1993020058A1 (en) 1993-10-14
NO943727D0 (no) 1994-10-05
DE69306559T2 (de) 1997-04-10
HUT68982A (en) 1995-08-28
IL105320A (en) 1998-02-08
HU9402863D0 (en) 1995-01-30
NO943727L (no) 1994-12-05
DE69306559D1 (de) 1997-01-23
CA2132745C (en) 2000-03-21
NO307088B1 (no) 2000-02-07
TW232014B (es) 1994-10-11
JPH07505392A (ja) 1995-06-15
AU667889B2 (en) 1996-04-18

Similar Documents

Publication Publication Date Title
TR199801919T2 (xx) Rapamisin t�revlerinin damar hastal�klar� ve yabanc� doku naklinde kullan�m�.
ATE194767T1 (de) In liposomen verkapseltes taxol und verwendungsverfahren
ES2152556T3 (es) Composiciones que contienen derivados del acido hidroperoxieicosatetraenoico y procedimientos de utilizacion en el tratamiento de trastornos de la sequedad ocular.
DE69019774D1 (de) Isochinolin-Derivate zur Behandlung des Glaukoms oder der okulären Hypertonie.
ATE107515T1 (de) Zusammensetzung zur behandlung von entzündung.
DE69526884D1 (de) Kombinationen von vasoaktiven Stoffen mit Fettsäuren zur Verhütung von Haarausfall
FI950909A (fi) Rasvahappojohdannaisia
ATE131154T1 (de) Phenylalkan(en)säuren.
FI931204A (fi) Nya, saosom lipooxigenasinhibitorer verkande aminobensosultamderivat
ES2098030T3 (es) Nuevos agentes cardioprotectores.
ES2181702T3 (es) Derivados de melatonina para su uso en el tratamiento de enfermedad es del sueño.
ATE141796T1 (de) 2',5'-oligoadenylat-derivate zur verwendung als heilmittel
ES2110602T3 (es) Nuevos derivados de 2,3-dihidro-2,2,4,6,7-pentaalquil-5-benzofuranoles.
DE3773059D1 (de) Ester von salsalat mit guajakol zur behandlung von phlogistischen bronchopneumopathien.
ES2082212T3 (es) Nuevos inhibidores de alfa-glucosidasa.
DE69429538D1 (de) Verwendung von 2-aminopurinderivaten zur behandlung und prophylaxe der menschlichen herpesvirus 6 infektionen
PH22606A (en) New use of 1,4-dihydropyridine derivatives
TR199701299A2 (xx) Vinilpirrolidon sefalasporin türevleri.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 635010

Country of ref document: ES